Effect of the dipeptide BDNF mimetic (compound GSB-106) on reflex development and monoamine levels in Wistar rats with an experimental autism spectrum disorder
Open Access
- 2 March 2026
- journal article
- Published by Publishing House OKI in Pharmacokinetics and Pharmacodynamics
- No. 4,p. 17-25
Abstract
Autism spectrum disorder (ASD) is a neurodevelopmental condition accompanied by alterations in serotonergic, dopaminergic, and noradrenergic systems, as well as delays in early psychomotor and sensorimotor development. One possible approach to correcting these disturbances is the use of BDNF mimetics that regulate synaptic plasticity and neurogenesis. The aim of this study was to investigate the effect of the low-molecular-weight dipeptide BDNF mimetic hexamethylenediamide bis(N-monosuccinyl-L-seryl-L-lysine) (GSB-106) on reflex development and monoamine content in the brain structures of Wistar rats with experimental ASD. The ASD model was induced by administration of sodium valproate (600 mg/kg) on gestation day 12.5. Offspring received GSB-106 orally at a dose of 0.1 mg/kg from postnatal day 7 to 21. The rate of sensorimotor reflex development was evaluated using the “Surface righting” and “Negative geotaxis” tests. Monoamines and their metabolites were quantified by high-performance liquid chromatography with electrochemical detection. GSB-106 improved negative geotaxis performance in both male and female rats with ASD (by 1.8–2.3 times), normalized NA and DOPAC levels in the frontal cortex of females, and reduced DA and 5-HT levels in male brain structures. Thus, GSB-106 exerts a normalizing effect on impaired early behavioral development and monoaminergic systems in rats with an ASD model, suggesting its potential as a promising compound for further investigation.Keywords
This publication has 20 references indexed in Scilit:
- Prevalence of co-occurring conditions in children and adults with autism spectrum disorder: A systematic review and meta-analysisNeuroscience & Biobehavioral Reviews, 2023
- Preventive effects of resveratrol against early-life impairments in the animal model of autism induced by valproic acidIBRO Neuroscience Reports, 2023
- The metabolic stress response: Adaptation to acute-, repeated- and chronic challenges in miceiScience, 2022
- Effect and mechanism of BDNF/TrkB signaling on vestibular compensationBioengineered, 2021
- The Role of the Noradrenergic System in Autism Spectrum Disorders, Implications for TreatmentSeminars in Pediatric Neurology, 2020
- Effects of the TrkB Receptor Agonist 7,8-Dihydroxyflavone on the Serotonin System and the Genes Encoding BDNF, TrkB, and Bax in the Mouse BrainNeuroscience and Behavioral Physiology, 2019
- BDNF mimetic alleviates body weight gain in obese mice by enhancing mitochondrial biogenesis in skeletal muscleMetabolism, 2018
- Prefrontal cortex modulates the correlations between brain-derived neurotrophic factor level, serotonin, and the autonomic nervous systemScientific Reports, 2018
- Sensitivity of hippocampal 5-HT1A receptors to mild stress in BDNF-deficient miceInternational Journal of Neuropsychopharmacology, 2013
- Embryological origin for autism: Developmental anomalies of the cranial nerve motor nucleiJournal of Comparative Neurology, 1996